GlassScriptPhysician profile
Christine Pan
NPI 1659613818
$10,657.15
in general payments reported to CMS, 2019-2025
26 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,607 · 2020: $324 · 2021: $6,311 · 2022: $645 · 2023: $744 · 2024: $724 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,699.26 | 2021 | |
| Coloplast Corp | $1,530.18 | 2019-2024 | |
| Axonics, INC. | $1,129.23 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $593.69 | 2020-2025 | Solyx Sis System, Axonics, Advantage System |
| Medtronic, INC. | $505.60 | 2021-2025 | Interstim, Signia |
| Caldera Medical, INC | $159.71 | 2021-2022 | |
| Astellas Pharma US INC | $154.88 | 2019-2023 | Myrbetriq |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Sage Therapeutics, LLC | $107.37 | 2020 | |
| Abbvie INC. | $91.36 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $84.69 | 2023-2025 | Gemtesa |
| Palette Life Sciences, INC. | $67.00 | 2022 | |
| Bluewind Medical | $49.86 | 2025 | Revi |
| Rochester Medical Corporation | $48.45 | 2022 | |
| Baxter Healthcare | $40.84 | 2024 | Perclot |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $39.76 | 2025 | Fibryga |
| Applied Medical Resources Corporation | $39.60 | 2024 | |
| Hologic Sales and Service, LLC | $31.46 | 2025 | Aptima, Thinprep 2000 Processor |
| Antares Pharma, INC. | $27.89 | 2022 | |
| Urovant Sciences INC | $22.89 | 2022 | |
| Avion Pharmaceuticals | $22.64 | 2023 | Balcoltra |
| Astrazeneca Pharmaceuticals LP | $20.07 | 2023 | Lynparza |
| Dilon Technologies, INC. | $19.69 | 2025 | Hemoblast Bellows |
| Cook Medical LLC | $16.02 | 2023 | Tornado |
| Tolmar Pharmaceuticals, INC. | $14.60 | 2022 | |
| Ambu INC. | $8.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.